NCT06061926View on ClinicalTrials.gov

Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

PHASE2RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Metabolic Syndrome
Interventions
DRUG

Celery Seed

Celery seed capsules (Apium graveolens L.) 150 mg twice times at day, one capsule with 75 mg before breakfast and one capsule with 75 mg before dinner during 12 weeks. Homologated to the other intervention. Oral administration.

DRUG

Placebo

Placebo capsules (calcined magnesia) twice times at day, one capsule before breakfast and one capsule before dinner during 12 weeks. Homologated to the other intervention. Oral administration.

Trial Locations (1)

44340

RECRUITING

INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universitario de Ciencias de la Salud, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER